Germany · Biopharma startup
Germany · CancerVAX Biotech
CancerVAX Biotech is a biotechnology company that develops universal cancer treatment using the body’s immune system.
Funding reportedLast round: Seed
Follow CancerVAX Biotech and see its new rounds in your feed.Start following
What company datasets say CancerVAX Biotech raised
Funding, as reported
Reported in all903kin the source's currency
Rounds1
Last roundSeed
Last round dateOct 2023
Funding filed with regulators
CancerVAX Biotech filed one raise, $903K in all. Filings say how much was sold and to how many investors; they never name the investors.
- May 2026$903KCrowdfunding
Biopharma in Germany
Startups like it
Is this your company?
Add your raise, your deck and your story, and put CancerVAX Biotech in front of investors. Or tell us what we have wrong.